PortfoliosLab logoPortfoliosLab logo
AVXL vs. KOD
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

AVXL vs. KOD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Anavex Life Sciences Corp. (AVXL) and Kodiak Sciences Inc. (KOD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

AVXL vs. KOD - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
AVXL
Anavex Life Sciences Corp.
-13.76%-66.85%15.36%0.54%-46.60%221.11%108.49%66.03%-37.35%
KOD
Kodiak Sciences Inc.
36.34%181.01%227.30%-57.54%-91.55%-42.29%104.18%913.38%-30.12%

Fundamentals

EPS

AVXL:

-$0.46

KOD:

-$4.11

Total Revenue (TTM)

AVXL:

$0.00

KOD:

$0.00

Gross Profit (TTM)

AVXL:

$0.00

KOD:

-$26.49M

EBITDA (TTM)

AVXL:

-$28.87M

KOD:

-$190.85M

Returns By Period

In the year-to-date period, AVXL achieves a -13.76% return, which is significantly lower than KOD's 36.34% return.


AVXL

1D
8.87%
1M
-30.70%
YTD
-13.76%
6M
-65.51%
1Y
-64.22%
3Y*
-28.98%
5Y*
-27.55%
10Y*
-4.82%

KOD

1D
13.25%
1M
42.24%
YTD
36.34%
6M
132.86%
1Y
1,259.00%
3Y*
83.20%
5Y*
-18.97%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AVXL vs. KOD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVXL
AVXL Risk / Return Rank: 1212
Overall Rank
AVXL Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
AVXL Sortino Ratio Rank: 1313
Sortino Ratio Rank
AVXL Omega Ratio Rank: 1111
Omega Ratio Rank
AVXL Calmar Ratio Rank: 1212
Calmar Ratio Rank
AVXL Martin Ratio Rank: 1212
Martin Ratio Rank

KOD
KOD Risk / Return Rank: 9999
Overall Rank
KOD Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
KOD Sortino Ratio Rank: 9999
Sortino Ratio Rank
KOD Omega Ratio Rank: 9898
Omega Ratio Rank
KOD Calmar Ratio Rank: 100100
Calmar Ratio Rank
KOD Martin Ratio Rank: 100100
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVXL vs. KOD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Anavex Life Sciences Corp. (AVXL) and Kodiak Sciences Inc. (KOD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AVXLKODDifference

Sharpe ratio

Return per unit of total volatility

-0.72

8.92

-9.64

Sortino ratio

Return per unit of downside risk

-0.87

5.47

-6.34

Omega ratio

Gain probability vs. loss probability

0.87

1.66

-0.79

Calmar ratio

Return relative to maximum drawdown

-0.81

37.34

-38.16

Martin ratio

Return relative to average drawdown

-1.40

73.29

-74.70

AVXL vs. KOD - Sharpe Ratio Comparison

The current AVXL Sharpe Ratio is -0.72, which is lower than the KOD Sharpe Ratio of 8.92. The chart below compares the historical Sharpe Ratios of AVXL and KOD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


AVXLKODDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.72

8.92

-9.64

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.33

-0.18

-0.16

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

0.19

-0.24

Correlation

The correlation between AVXL and KOD is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

AVXL vs. KOD - Dividend Comparison

Neither AVXL nor KOD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AVXL vs. KOD - Drawdown Comparison

The maximum AVXL drawdown since its inception was -97.06%, roughly equal to the maximum KOD drawdown of -99.15%. Use the drawdown chart below to compare losses from any high point for AVXL and KOD.


Loading graphics...

Drawdown Indicators


AVXLKODDifference

Max Drawdown

Largest peak-to-trough decline

-97.06%

-99.15%

+2.09%

Max Drawdown (1Y)

Largest decline over 1 year

-79.57%

-32.40%

-47.17%

Max Drawdown (5Y)

Largest decline over 5 years

-90.51%

-98.91%

+8.40%

Max Drawdown (10Y)

Largest decline over 10 years

-90.51%

Current Drawdown

Current decline from peak

-89.36%

-76.82%

-12.54%

Average Drawdown

Average peak-to-trough decline

-64.88%

-63.68%

-1.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.14%

16.51%

+29.63%

Volatility

AVXL vs. KOD - Volatility Comparison

The current volatility for Anavex Life Sciences Corp. (AVXL) is 47.17%, while Kodiak Sciences Inc. (KOD) has a volatility of 61.06%. This indicates that AVXL experiences smaller price fluctuations and is considered to be less risky than KOD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


AVXLKODDifference

Volatility (1M)

Calculated over the trailing 1-month period

47.17%

61.06%

-13.89%

Volatility (6M)

Calculated over the trailing 6-month period

82.27%

87.44%

-5.17%

Volatility (1Y)

Calculated over the trailing 1-year period

88.81%

142.85%

-54.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

83.16%

108.72%

-25.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.60%

104.86%

-19.26%

Financials

AVXL vs. KOD - Financials Comparison

This section allows you to compare key financial metrics between Anavex Life Sciences Corp. and Kodiak Sciences Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober00
(AVXL) Total Revenue
(KOD) Total Revenue
Values in USD except per share items